Real-world use of the FIB-4 calculator in primary care workflows to screen for advanced non-alcoholic fatty liver disease in a large US health system

被引：0

作者：

Therapondos, George ^{[1
]}

Thomas, Anna ^{[2
]}

Dieterich, Douglas T. ^{[3
]}

Girgrah, Nigel ^{[1
]}

Oravetz, Philip ^{[4
]}

机构：

[1] Ochsner Hlth, Multiorgan Transplant, New Orleans, LA USA

[2] NASHNET, Kiev, Ukraine

[3] Icahn Sch Med, Dept Med, New York, NY USA

[4] Ochsner Hlth, Populat Hlth, New Orleans, LA USA

来源：

JOURNAL OF HEPATOLOGY | 2022年 / 77卷

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

FRI070

引用

页码：S432 / S432

页数：1

共 50 条

[21] REAL-WORLD HEALTHCARE RESOURCE UTILIZATION AND COSTS AMONG PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE ARE SUBSTANTIAL AND INCREASE WITH ADVANCED DISEASE
Siddiqui, Mohammad B.
Myers, Joel
Byrne, Clare
Wang, Yuexi
Tang, Jackson
Ogbomo, Adesuwa
Qiu, Ying
HEPATOLOGY, 2020, 72 : 990 - 990
[22] Presence and severity of non-alcoholic fatty liver disease in a large prospective primary care cohort
Armstrong, Matthew J.
Houlihan, Diarmaid D.
Bentham, Louise
Shaw, Jean C.
Cramb, Robert
Olliff, Simon
Gill, Paramjit S.
Neuberger, James M.
Lilford, Richard J.
Newsome, Philip N.
JOURNAL OF HEPATOLOGY, 2012, 56 (01) : 234 - 240
[23] Fibroscan™, FIB-4, and NAFLD Fibrosis Score as Point of Care Non-Invasive Tests for Management of Non-Alcoholic Fatty Liver Disease and Other Chronic Liver Diseases
Younossi, Zobair
Stepanova, Maria
Felix, Sean
Jeffers, Tom
Younossi, Elena
Allawi, Hossain
Cable, Rebecca
Lam, Brian
Racila, Andrei
Younossi, Issah
Henry, Linda
Ranagan, Jane
Nader, Fatema
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2019, 114 : S567 - S568
[24] PROGNOSTIC VALUE OF LIVER STIFFNESS AND FIB-4 SCORE IN INDIVIDUALS WITH CIRRHOSIS DUE TO NON-ALCOHOLIC FATTY LIVER DISEASE WITHOUT PREVIOUS LIVER DECOMPENSATION
Abdulle, A.
Armandi, A.
Caviglia, G. P.
Rosso, C.
D'Amato, D.
Castelnuovo, G.
Del Campo, Perez Diaz N.
Gjini, K.
Poggiolini, I
Guariglia, M.
Saracco, G. M.
Bugianesi, E.
DIGESTIVE AND LIVER DISEASE, 2023, 55 : S165 - S166
[25] Semaglutide Outcomes in Non-Alcoholic Fatty Liver Disease: A Multi-Centered Real-World Study
Ghusn, Wissam
Fansa, Sima
Anazco, Diego
Tama, Elif
Nicolalde, Bryan
Gala, Khushboo
Cifuentes, Lizeth
De La Rosa, Alan
Sacoto, Daniel
Campos, Alejandro
Feris, Fauzi
Acosta, Andres
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2023, 118 (10): : S1127 - S1128
[26] Evaluation of NAFLD fibrosis, FIB-4 and APRI score in diabetic patients receiving exenatide treatment for non-alcoholic fatty liver disease
Unsal, Ilknur Ozturk
Calapkulu, Murat
Sencar, Muhammed Erkam
Cakal, Basak
Ozbek, Mustafa
SCIENTIFIC REPORTS, 2022, 12 (01)
[27] Increasing risk of disease progression and mortality in nonalcoholic fatty liver disease/non-alcoholic steatohepatitis patients with advanced liver disease: A german real-world analysis
Canbay, Ali
Kachru, Nandita
Meise, Dominic
Haas, Jennifer Scarlet
Ozbay, Ahmet Burak
JOURNAL OF HEPATOLOGY, 2019, 70 (01) : E36 - E36
[28] Evaluation of NAFLD fibrosis, FIB-4 and APRI score in diabetic patients receiving exenatide treatment for non-alcoholic fatty liver disease
İlknur Ozturk Unsal
Murat Calapkulu
Muhammed Erkam Sencar
Basak Cakal
Mustafa Ozbek
Scientific Reports, 12
[29] Ultrasonographic grayscale findings related to fibrosis in patients with non-alcoholic fatty liver disease: comparison with transient elastography and Fib-4 index
Naoki Matsumoto
Mariko Kumagawa
Masahiro Ogawa
Masahiro Kaneko
Yukinobu Watanabe
Hiroshi Nakagawara
Ryota Masuzaki
Tatsuo Kanda
Mitsuhiko Moriyama
Masahiko Sugitani
Journal of Medical Ultrasonics, 2021, 48 : 323 - 333
[30] Ultrasonographic grayscale findings related to fibrosis in patients with non-alcoholic fatty liver disease: comparison with transient elastography and Fib-4 index
Matsumoto, Naoki
Kumagawa, Mariko
Ogawa, Masahiro
Kaneko, Masahiro
Watanabe, Yukinobu
Nakagawara, Hiroshi
Masuzaki, Ryota
Kanda, Tatsuo
Moriyama, Mitsuhiko
Sugitani, Masahiko
JOURNAL OF MEDICAL ULTRASONICS, 2021, 48 (03) : 323 - 333

← 1 2 3 4 5 →